Anticancer Drugs Discovery and Development from Marine Organisms | Bentham Science
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Anticancer Drugs Discovery and Development from Marine Organisms

Author(s): Chiranjib Chakraborty, Chi-Hsin Hsu, Zhi-Hong Wen and Chan-Shing Lin

Volume 9, Issue 16, 2009

Page: [1536 - 1545] Pages: 10

DOI: 10.2174/156802609789909803

Price: $65

Open Access Journals Promotions 2
Abstract

The chemical and biological diversity of the different marine evolutionary group is endless and therefore, this is an amazing resource for the discovery of new anticancer drugs. Comprising 34 of the 36 Phyla of life, marine ecosystems are indeed our last genetic diversity and biotechnological boundary; terrestrial systems possess only 17 Phyla. Sponges, coelenterates and microorganisms are the foremost resources of therapeutic compounds. Algae, echinoderms, tunicates, mollusks, bryozoans are also the sources of anticancer drugs from marine resources. We highlight the past and current status of marine anticancer pharmacology using different marine groups.

Keywords: Anticancer drugs discovery, marine families and evolution, marine biodiversity


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy